Ignite Creation Date:
2025-12-24 @ 7:07 PM
Ignite Modification Date:
2026-05-04 @ 4:10 AM
Study NCT ID:
NCT00004057
Status:
COMPLETED
Last Update Posted:
2013-06-21
First Post:
1999-12-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | recurrent adult Hodgkin lymphoma | View |
| None | unspecified adult solid tumor, protocol specific | View |
| None | recurrent grade 1 follicular lymphoma | View |
| None | recurrent grade 2 follicular lymphoma | View |
| None | recurrent grade 3 follicular lymphoma | View |
| None | recurrent adult diffuse small cleaved cell lymphoma | View |
| None | recurrent adult diffuse mixed cell lymphoma | View |
| None | recurrent adult diffuse large cell lymphoma | View |
| None | recurrent adult immunoblastic large cell lymphoma | View |
| None | recurrent adult lymphoblastic lymphoma | View |
| None | recurrent adult Burkitt lymphoma | View |
| None | recurrent adult T-cell leukemia/lymphoma | View |
| None | recurrent mantle cell lymphoma | View |
| None | angioimmunoblastic T-cell lymphoma | View |
| None | anaplastic large cell lymphoma | View |
| None | recurrent marginal zone lymphoma | View |
| None | recurrent small lymphocytic lymphoma | View |
| None | extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue | View |
| None | nodal marginal zone B-cell lymphoma | View |
| None | splenic marginal zone lymphoma | View |